Investor Relations

Our investor relations work focuses on maintaining an ongoing, open dialogue with shareholders, potential investors and financial analysts. Therefore, as part of our reporting, we regularly disclose detailed information about our strategic approach, the current progress of our business and about our prospects.

Here, you will find a wide range of facts and figures about Sartorius AG and Sartorius Stedim Biotech S.A., the respective shares as well as about our current business development.
Information on the corporate governance of Sartorius AG can be found here

Sartorius AG

Sartorius Stedim Biotech S.A.

ISIN: DE0007165607 & DE0007165631

ISIN: FR0000053266